跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABILIFY 30 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ABILIFY 30 MG COMPRIMIDOS
Approved
STANDARD
ABILIFY 30 MG COMPRIMIDOS
Otsuka Pharmaceutical Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 8, 2026
Approval ID
e364f313bd6c35cf
Company
Otsuka Pharmaceutical Netherlands B.V.
Type
Standard
Approval Details
Approval Id
e364f313bd6c35cf
Drug Cima Aemps Name
ABILIFY 30 MG COMPRIMIDOS
Register Number
04276017IP2
Holder Company Name
Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date
2026-09-08
Dosage Form
COMPRIMIDO
Dose
30 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path
/organization/otsuka-pharmaceutical-netherlands-b-v
Company Information
Pharmaceutical Company Name
Otsuka Pharmaceutical Netherlands B.V.
Country Name
Netherlands
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 8, 2026
Approval ID
e364f313bd6c35cf
Type
Standard
Back to CIMA-AEMPS Approvals